Samoa ends measles state of emergency as infection rate slows
By Will Ziebell MELBOURNE (Reuters) – The South Pacific island nation of Samoa has lifted a...
Read More
Updated
Chicken pox outbreak forces migrant shelter to shutter in northern Mexico
By Julio-Cesar Chavez CIUDAD JUAREZ, Mexico (Reuters) – An outbreak of chicken pox has...
Read More
China’s top pig producing region vows to return to normal levels in 2020
BEIJING (Reuters) – China’s top pig producer Sichuan province pledged to produce 60...
Read MoreAlmost 10 million in U.S. have faced sexual violence at work
By Carolyn Crist (Reuters Health) – Almost 1 in 18 women and 1 in 40 men have experienced sexual harassment in and related to the workplace, according to a U.S. study. That represents almost 7 million women and 3 million...
Read More
Recreational marijuana becomes legal in Illinois on New Year’s Day
By Brendan O’Brien CHICAGO (Reuters) – Many pot-smoking adults in Illinois will ring...
Read More
Allergan signs $750 million settlement with purchasers of Alzheimer’s drug Namenda
By Jonathan Stempel NEW YORK (Reuters) – Purchasers of Allergan Plc’s Namenda asked a...
Read More
Swapping out eggs, white bread for oatmeal linked to lowered stroke risk
By Lisa Rapaport (Reuters Health) – People who eat oatmeal for breakfast instead of eggs and...
Read More
Doctors and nurses in the UK not honored as often as other professions
By Ruhi Soni (Reuters Health) – People in the healthcare industry are less likely than those...
Read MoreU.S. safety monitoring program for lifesaving devices may not be adequate
(This Dec.23 story adds dropped letter to Marc, in the 13th paragraph) By Linda Carroll (Reuters Health) – The system in place to monitor safety of medical devices in the United States may not catch failures soon enough to...
Read MoreCorrevio’s heart drug fails to get FDA approval
(Reuters) – The U.S. Food and Drug Administration has declined to approve Correvio Pharma Corp’s drug to correct irregular rhythm in the upper chambers of the heart, the company said on Tuesday. In the so-called...
Read More
Roche dives deeper into gene therapy with $1.15 billion Sarepta licensing deal
(Reuters) – Roche Holding AG made its second major gene therapy deal in a year on Monday,...
Read More
Allergan’s acute migraine treatment wins U.S. FDA approval
By Manojna Maddipatla (Reuters) – The U.S. Food and Drug Administration said on Monday it...
Read More
AstraZeneca, Daiichi’s breast cancer drug gets accelerated approval from FDA
(This Dec.20 story corrects first paragraph to say the approval came four months ahead of...
Read More
Unmarried Chinese woman sues hospital over refusal to freeze eggs
By Huizhong Wu BEIJING (Reuters) – An unmarried Chinese woman filed a suit against a...
Read MoreFDA approves Intra-Cellullar’s schizophrenia drug, shares soar 85%
By Trisha Roy (Reuters) – Intra-Cellular Therapies Inc said on Monday its lead drug to treat schizophrenia in adults has received approval from the U.S. Food and Drug Administration, sending its shares soaring 85%. The...
Read More
Eisai Inc announces U.S. approval for insomnia drug
By Trisha Roy (Reuters) – Japan-based drugmaker Eisai Co’s U.S. subsidiary announced...
Read More
Merck says Ebola vaccine to be available at lowest access price for poor nations
(Reuters) – Merck & Co <MRK.N> said on Friday it expects to make licensed doses of...
Read More
Canadian drug distributors say no to Trump import plan
By Allison Martell TORONTO (Reuters) – Many of Canada’s drug suppliers cannot, or will...
Read More
Sign-ups for 2020 Obamacare insurance on HealthCare.gov fall to 8.3 million: CMS
(Reuters) – Enrollments for 2020 insurance plans, under the Affordable Care Act (ACA), on...
Read More
As U.S. vaping injuries taper off, new evidence points to vitamin E
By Julie Steenhuysen CHICAGO (Reuters) – The U.S. Centers for Disease Control and Prevention...
Read More